< Back to search
Filter
1
Active & Responsive

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

for
CD30-Positive Diffuse Large B-Cell Lymphoma,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 12 - 70+

Code: NCT06176690

Phase1, Recruiting
New

Study of NXP900 With Lorlatinib in ALK+ Lung Cancer

for
ALK Positive, ALK Positive Non-small Cell Lung Cancer, NSCLC,
Location: Fairfax VA
Sponsor: Nuvectis Pharma, Inc.

Sex: All

Age: 0+

Code: NCT07784959

Phase1, Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Boston MA, Providence RI, The Bronx NY, New York NY,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT05544019

Phase1, Recruiting

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: Boston MA, New York NY, Fairfax VA, Durham NC,
Sponsor: TRIANA Biomedicines, Inc.

Sex: All

Age: 18+

Code: NCT07491497

Phase1, Phase2, Recruiting

Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL

for
Anaplastic Large Cell Lymphoma, ALK-Positive
Location: Valhalla NY
Sponsor: New York Medical College

Sex: All

Age: 1 - 39

Code: NCT07013565

Phase2, Recruiting

Interested in new alk gene rearrangement trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Patient-centered, Optimal Integration of Survivorship and Palliative Care

for
Stage IV Non-small Cell Lung Cancer, Targeted Therapy,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04900935

Recruiting

A Registry for People With T-cell Lymphoma

for
T-cell Lymphoma, NK-Cell Lymphoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0+

Code: NCT05978141

Recruiting

International Rare Histiocytic Disorders Registry (IRHDR)

for
Rare Histiocytic Disorders (RHDs),
Location: Boston MA, New York NY, Toronto, Pittsburgh PA,
Sponsor: The Hospital for Sick Children

Sex: All

Age: 0+

Code: NCT02285582

Recruiting

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

for
Large B-Cell Lymphoma With IRF4 Rearrangement,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06834373

Phase2, Recruiting

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer (NSCLC),
Location: Hackensack NJ, Fairfax VA, Atlanta GA, Ann Arbor MI,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07140016

Phase1, Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

for
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Location: Boston MA, Westbury NY, New York NY, Sellersville PA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06765109

Phase3, Recruiting